Please select the option that best describes you:
Topics:
Internal Medicine • Cardiology • Cardiac Electrophysiology • Adult Congenital Heart Disease • Cardiovascular Imaging • Advanced Heart Failure and Transplant • Geriatric Cardiology • Interventional Cardiology • Structural Heart Disease • Autonomics and Hypertension • Peripheral Vascular Disease • Cardio-Obstetrics • Critical Care Cardiology • Sports Cardiology • Preventive Cardiology
What are your top takeaways from AHA 2023?
Answer from: at Academic Institution
SELECT trial
ARIES-HM3 trial
SPEC-AI trial
Sign in or Register to read more
Answer from: at Academic Institution
Cardiac benefits of weight loss therapy; benefits of sodium reduction on BP, no need for aspirin with VAD therapy.
Answer from: at Community Practice
The Sudden Cardiac Death in National Collegiate Athletic Associate Athletes: A 20-year study which was simultaneously published in Circulation. Petek et al., PMID 37955565
Arrhythmic risk in Biventricular pacing compared with left bundle branch area pacing. Herweg et al., PMID 37950738
Off-label...
Answer from: at Academic Institution
I think the most exciting is the factor XI antibody phase II trial that was stopped early (Azalea TIMI 71). Clearly, more studies are needed especially to delineate efficacy, but the safety profile of this drug seems great and holds a lot of promise.ARTESIA is also interesting but probably poses mor...